These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36309421)

  • 1. Androgenic Steroids Use and Abuse: Past, Present, and Future.
    Thirumalai A; Anawalt BD
    Urol Clin North Am; 2022 Nov; 49(4):645-663. PubMed ID: 36309421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on anabolic-androgenic steroid abuse.
    Lukas SE
    Trends Pharmacol Sci; 1993 Feb; 14(2):61-8. PubMed ID: 8480376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.
    Nieschlag E; Vorona E
    Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of androgenic-anabolic steroids in athletes.
    Hartgens F; Kuipers H
    Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping with testosterone and androgenic/anabolic steroids: Impact on health, screening tools and medical care.
    Young J
    Ann Endocrinol (Paris); 2023 May; 84(3):401-405. PubMed ID: 36990315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxic effects of cocaine and anabolic-androgenic steroids in the athlete.
    Welder AA; Melchert RB
    J Pharmacol Toxicol Methods; 1993 Apr; 29(2):61-8. PubMed ID: 8318715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Management of Anabolic Androgenic Steroid Use.
    Anawalt BD
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions.
    Nieschlag E; Vorona E
    Eur J Endocrinol; 2015 Aug; 173(2):R47-58. PubMed ID: 25805894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of anabolic steroids in athletes. A constant threat.
    Maravelias C; Dona A; Stefanidou M; Spiliopoulou C
    Toxicol Lett; 2005 Sep; 158(3):167-75. PubMed ID: 16005168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping in sport: effects, harm and misconceptions.
    Birzniece V
    Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out].
    de Ronde W
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1820-4. PubMed ID: 18783159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
    Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
    Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.
    Deshmukh N; Petróczi A; Barker J; Székely AD; Hussain I; Naughton DP
    Subst Abuse Treat Prev Policy; 2010 Apr; 5():7. PubMed ID: 20429943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgenic steroid excess in women.
    Karila D; Kerlan V; Christin-Maitre S
    Ann Endocrinol (Paris); 2024 Apr; 85(2):142-149. PubMed ID: 38040089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous manifestations of anabolic-androgenic steroid use in athletes.
    Walker J; Adams B
    Int J Dermatol; 2009 Oct; 48(10):1044-8; quiz 1048. PubMed ID: 19785085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position stand on androgen and human growth hormone use.
    Hoffman JR; Kraemer WJ; Bhasin S; Storer T; Ratamess NA; Haff GG; Willoughby DS; Rogol AD
    J Strength Cond Res; 2009 Aug; 23(5 Suppl):S1-S59. PubMed ID: 19620932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.